Schedule 13D ownership disclosure

JASPER THERAPEUTICS INC

Voting Common Stock, par value $0.0001 per share · CUSIP: 471871202

Event date: 2025-09-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Velan Capital Master Fund LPReported CIK 0001964356

    Shares: 2,381,915.00 · Class: 8.5%

  • Velan Capital Holdings LLCReported CIK 0001964353

    Shares: 2,381,915.00 · Class: 8.5%

  • Velan Horizon Fund LPReported CIK 0002057740

    Shares: 41,152.00 · Class: 0.1%

  • Velan Horizon GP LLCReported CIK 0002057821

    Shares: 41,152.00 · Class: 0.1%

  • Avego Healthcare Capital, L.P.Reported CIK 0001822834

    Shares: 245,328.00 · Class: 0.9%

  • Avego Healthcare Capital Holdings, LLCReported CIK 0001964446

    Shares: 245,328.00 · Class: 0.9%

  • Avego Management LLCReported CIK 0001886177

    Shares: 245,328.00 · Class: 0.9%

  • Velan Capital Investment Management LPReported CIK 0001848809

    Shares: 2,668,395.00 · Class: 9.6%

  • Velan Capital Management LLCReported CIK 0001964355

    Shares: 2,668,395.00 · Class: 9.6%

  • Morgan AdamReported CIK 0001964335

    Shares: 2,668,395.00 · Class: 9.6%

  • VENKATARAMAN BALAJIReported CIK 0001114916

    Shares: 2,668,395.00 · Class: 9.6%

  • Kapoor VishalReported CIK 0001798946

    Shares: 23,867.00 · Class: 0.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-002600
Form type
SCHEDULE 13D/A
Filer
Jasper Therapeutics, Inc.
CIK
CIK 1788028
Filed
Sep 23, 2025
Reporting period
Sep 19, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub